BRIEF published on 07/31/2024 at 08:05, 3 months 24 days ago Britvic PLC Announces Employee Representatives' Opinion on Carlsberg UK Holdings Acquisition Acquisition Takeover Code Britvic Carlsberg Employee Opinion
PRESS RELEASE published on 07/31/2024 at 08:00, 3 months 24 days ago Employee Representatives' Opinion Britvic plc announces employee representatives' opinions on the recommended cash acquisition by Carlsberg UK Holdings Limited. Details available on Britvic's website Britvic Plc Employee Representatives Cash Acquisition Carlsberg UK Holdings Limited Opinion
BRIEF published on 07/29/2024 at 15:21, 3 months 26 days ago The Vanguard Group Discloses Position in Britvic plc Securities Disclosure Takeover Code Vanguard Britvic
PRESS RELEASE published on 07/29/2024 at 15:16, 3 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.40% ownership of Britvic plc's 20p ordinary shares as of 26 July 2024. Purchase and sale transactions executed The Vanguard Group, Inc. Britvic Plc Ownership Disclosure Purchase And Sale Transactions 20p Ordinary Shares
BRIEF published on 07/26/2024 at 15:13, 3 months 29 days ago Vanguard Group Discloses Stake in Britvic plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Britvic Stake
PRESS RELEASE published on 07/26/2024 at 15:08, 3 months 29 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.40% ownership of Britvic plc shares on 25 July 2024 per Form 8.3 filing Form 8.3 Britvic Plc The Vanguard Group Ownership Disclosure Stock Holdings
BRIEF published on 07/25/2024 at 15:25, 3 months 30 days ago The Vanguard Group, Inc. Discloses Position in Britvic plc Securities Disclosure Takeover Code Vanguard Britvic
PRESS RELEASE published on 07/25/2024 at 15:20, 3 months 30 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.40% stake in Britvic plc. Purchase of 20p ordinary shares at 12.64 GBP per unit disclosed Britvic Plc Vanguard Group Financial Disclosure Share Purchase Stake Disclosure
BRIEF published on 07/24/2024 at 15:09, 4 months ago Vanguard Group Discloses Significant Interest in Britvic Plc Securities Disclosure Britvic Plc Takeover Code Vanguard Group
PRESS RELEASE published on 07/24/2024 at 15:04, 4 months ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.40% stake in Britvic plc as of 23 July 2024. Purchase of 5070 securities at 12.66 GBP per unit Britvic Plc The Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase
Published on 11/22/2024 at 23:55, 1 day 23 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 2 days 1 hour ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/24/2024 at 19:16, 4 hours 21 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/24/2024 at 19:07, 4 hours 30 minutes ago EQS-Adhoc: ABO Energy KGaA reduces forecast for the 2024 annual result to EUR 20 to 25 million and confirms market expectation for the 2025 financial year
Published on 11/22/2024 at 18:14, 2 days 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 2 days 5 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 06:58, 3 days 16 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 5 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days 5 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
